NO865302L - Fremgangsmaate for fremstilling av immunoforsterkere og beslektede forbindelser. - Google Patents

Fremgangsmaate for fremstilling av immunoforsterkere og beslektede forbindelser.

Info

Publication number
NO865302L
NO865302L NO865302A NO865302A NO865302L NO 865302 L NO865302 L NO 865302L NO 865302 A NO865302 A NO 865302A NO 865302 A NO865302 A NO 865302A NO 865302 L NO865302 L NO 865302L
Authority
NO
Norway
Prior art keywords
immuno
amplifiers
procedure
manufacture
related relations
Prior art date
Application number
NO865302A
Other languages
English (en)
Norwegian (no)
Other versions
NO865302D0 (no
Inventor
Arthur A Gottlieb
Original Assignee
Imreg Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/813,632 external-priority patent/US4699898A/en
Application filed by Imreg Inc filed Critical Imreg Inc
Publication of NO865302D0 publication Critical patent/NO865302D0/no
Publication of NO865302L publication Critical patent/NO865302L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/12—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO865302A 1985-12-26 1986-12-23 Fremgangsmaate for fremstilling av immunoforsterkere og beslektede forbindelser. NO865302L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/813,632 US4699898A (en) 1985-12-26 1985-12-26 Tripeptides affecting immune response
US90268386A 1986-09-02 1986-09-02

Publications (2)

Publication Number Publication Date
NO865302D0 NO865302D0 (no) 1986-12-23
NO865302L true NO865302L (no) 1987-06-29

Family

ID=27123762

Family Applications (1)

Application Number Title Priority Date Filing Date
NO865302A NO865302L (no) 1985-12-26 1986-12-23 Fremgangsmaate for fremstilling av immunoforsterkere og beslektede forbindelser.

Country Status (9)

Country Link
EP (1) EP0230052B1 (fr)
JP (1) JP2502553B2 (fr)
AU (1) AU619441B2 (fr)
CA (1) CA1286989C (fr)
DE (1) DE3689767T2 (fr)
DK (1) DK612786A (fr)
FI (1) FI865267A (fr)
IL (1) IL81072A0 (fr)
NO (1) NO865302L (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3782958D1 (de) * 1986-02-19 1993-01-21 Imreg Inc Verfahren und mittel zum pruefen eines immunsystems.
US4880779A (en) * 1987-07-31 1989-11-14 Research Corporation Technologies, Inc. Method of prevention or treatment of AIDS by inhibition of human immunodeficiency virus
CA1340588C (fr) * 1988-06-13 1999-06-08 Balraj Krishan Handa Derive d'aminoacides
GB8927913D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Amino acid derivatives
DE4303530C2 (de) * 1993-02-06 1997-04-03 Milan C Dr Med Pesic Pharmazeutische Verwendung eines Enkephalins
RU2107692C1 (ru) 1995-06-07 1998-03-27 Дейгин Владислав Исакович Пептид и способ его получения
RU2107691C1 (ru) 1995-03-02 1998-03-27 Дейгин Владислав Исакович Пептид и способ его получения
US7632818B2 (en) * 2003-03-20 2009-12-15 Gottlieb Marise S Method for treating conditions associated with the Metabolic Syndrome (Syndrome X)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI78483C (fi) * 1980-05-14 1989-08-10 A Arthur Gottlieb Rening av modulatorer foer immunsystem.
US4468379A (en) * 1982-05-06 1984-08-28 Endeavor Corp. Leukocyte extracts for affecting the immune system
DK134784A (da) * 1983-03-07 1984-09-08 Lilly Co Eli Farmakologisk virksomme tripeptid-derivater og fremgangsmaade til fremstilling deraf
US4599325A (en) * 1984-02-16 1986-07-08 G. D. Searle & Co. Substituted tyrosyl alanine dipeptide amides
US4616079A (en) 1984-08-24 1986-10-07 Imreg, Inc. Immunoamplifiers and processes for the extraction thereof
US4710380A (en) 1986-04-04 1987-12-01 Imreg, Inc. Treatment of autoimmune disorders with immunoamplifiers

Also Published As

Publication number Publication date
DE3689767T2 (de) 1994-08-25
JP2502553B2 (ja) 1996-05-29
EP0230052B1 (fr) 1994-04-06
IL81072A0 (en) 1987-03-31
NO865302D0 (no) 1986-12-23
EP0230052A2 (fr) 1987-07-29
CA1286989C (fr) 1991-07-30
DK612786A (da) 1987-06-27
FI865267A (fi) 1987-06-27
AU6697086A (en) 1987-07-02
JPS62228023A (ja) 1987-10-06
DE3689767D1 (de) 1994-05-11
DK612786D0 (da) 1986-12-18
FI865267A0 (fi) 1986-12-22
EP0230052A3 (en) 1989-08-30
AU619441B2 (en) 1992-01-30

Similar Documents

Publication Publication Date Title
NO854884L (no) Keramisk formdel og anvendelse av denne.
NO882762D0 (no) Fremgangsmaate for fremstilling av antihypertensive og antiarytmiske forbindelser.
NO890045L (no) Baatskrog og fremgangsmaate for fremstilling og belegging derav.
DK461387A (da) Fremgangsmaade til fremstilling af optegnelsesark og anvendelse deraf til fremstilling af flexotrykforme.
NO853120L (no) Isfjell og fremgangsmaate for fremstilling av samme.
NO862853D0 (no) Fremgangsmaate for fremstilling av askefattig og elektrisk ledende sot.
NO882940D0 (no) Fremgangsmaate for fremstilling av castanosperminestere og glycosider.
NO865302L (no) Fremgangsmaate for fremstilling av immunoforsterkere og beslektede forbindelser.
NO156383C (no) Vernegitter e.l. og framgangsmŸte for tilvirking av dette.
NO863378D0 (no) Fremgangsmaate og anordning for fremstilling av varmeisolerte roerledninger.
NO851452L (no) Fremgangsmaate og cellelinje for fremstilling av plasminogene aktivatorer.
NO881713D0 (no) Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.
NO860507L (no) Fremgangsmaate for fremstilling av arylglycidyletere og 3-substituerte 1-alkylamino-2-propanoler.
NO863113D0 (no) Fremgangsmaate for fremstilling av heterocyclocarbonyl- og acetyl-thiazoloner.
NO891630D0 (no) Fremgangsmaate og anordning for fremstilling av diafragmer.
NO880592L (no) Herdbare harpikser, fremgangsmaate for fremstilling av disse og anvendelse av disse.
NO882336L (no) Fremgangsmaate for fremstilling av 5-metoksyalkylammoniun-tetrahydrofuraner og tetrahydrotiofener.
NO862823L (no) Fremgangsmaate for fremstilling av lenser og liknende.
DE3880552D1 (de) Polyaether-polyamid-blockcopolymer und polyaether-praepolymer.
NO163885C (no) Fremgangsmaate og innretning for korrugering av metallroer.
NO165956C (no) Fremgangsmaate for fremstilling av hydrokarboner og oksygenerte hydrokarboner.
NO164530C (no) Fremgangsmaate for fremstilling av blandingssprengstoffer av typen hexotonal og octonal.
NO861324L (no) Anordning og fremgangsmaate for fremstilling av polymeriske legemer.
NO874487D0 (no) Framgangsmaate for tilvirkning av poelser og liknende produkter.
NO912279L (no) Fremgangsmaate for fremstilling og anvendelse av eksplosjonssikre 1-dimetylamino-3-dimetylimino-2-arylprop-1-en-salter.